Pathoseq Bio, LLC
Omaha, NE
- UEI
- XZBGAKEK7K55
- CAGE
- 8R6V6
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Sole Proprietorship
- NAICS codes registered in SAM.gov
-
- 541714 Research and Development in Biotechnology (except Nanobiotechnology) Primary
- 541511 Custom Computer Programming Services
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- 541990 All Other Professional, Scientific, and Technical Services
- 611430 Professional and Management Development Training
- 621511 Medical Laboratories
- SAM.gov registration date
- Physical address
- 4982 S 177th Cir, Omaha, NE 68135, USA
- Website
- praesensfoundation.org
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Industrials
- Commercial & Professional Services
- Professional Services
- Research & Consulting Services
- SIC code
- 87 Engineering & Management Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| FFP labor | Naval Supply Systems Command | $247,497 | |
| Genomic analysis | Naval Supply Systems Command | $155,106 | |
| Medical research and development service | Naval Supply Systems Command | $247,866 | |
| Sequence based detection biothreat agent | Naval Supply Systems Command | $247,372 | |
| Sequence-based characterization of sars | Naval Supply Systems Command | $248,637 |
About Pathoseq Bio, LLC
Pathoseq Bio, LLC is a small business limited liability company based in Omaha, Nebraska, that specializes in advanced biological research, genomic analysis, and biothreat detection services for federal defense and medical research agencies. The company is registered in SAM.gov and maintains an active registration through July 2026. Since its registration in May 2020, Pathoseq Bio has established itself as a specialized contractor supporting the U.S. Department of the Navy's medical research and biosurveillance objectives through its proprietary Pan-Viral Panel technology, which is compatible with Oxford Nanopore Technologies MinION sequencing devices. The company's expertise in genomic analysis and its ability to detect biothreat agents, arboviruses, and antibiotic-resistant organisms have positioned it as a sought-after provider for critical national security and public health initiatives.
Pathoseq Bio has received three firm fixed-price purchase order contracts from the Department of the Navy's Bureau of Medicine and Surgery, ranging in value from $155,106 to $247,866. The first contract, awarded July 1, 2024, for $247,866 was set aside for total small business participation and involved medical research and development services with a performance period extending through September 30, 2025. The second contract, awarded July 9, 2024, valued at $155,106 and also set aside for total small business participation, focused on genomic analysis services with a completion date of March 31, 2025. The most recent contract, awarded September 23, 2025, for $247,497 and not utilizing a set-aside designation, was awarded as a sole source contract for bioinformatic services supporting NAMRU Indo-Pacific's biosurveillance initiatives across the Indo-Pacific Command Area of Responsibility. This latest contract leverages Pathoseq Bio's unique Pan-Viral Panel technology to support health facilities and infectious disease surveillance networks across Malaysia, Laos, Vietnam, the Philippines, South Korea, Taiwan, and Papua New Guinea, with primary performance on the U.S. West Coast and potential wet-lab training at partner locations throughout the region. The contract work includes developing standardized laboratory procedures and consensus genomes for detecting biothreat agents, with completion scheduled for September 22, 2026.
SBA capabilities narrative
Next-generation sequencing-based infectious disease diagnostics
Quick answers
What is Pathoseq Bio, LLC's UEI?
Pathoseq Bio, LLC's Unique Entity ID (UEI) in SAM.gov is XZBGAKEK7K55.
What is Pathoseq Bio, LLC's CAGE code?
Pathoseq Bio, LLC's CAGE code is 8R6V6.
What is Pathoseq Bio, LLC's primary NAICS code?
Pathoseq Bio, LLC's primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Where is Pathoseq Bio, LLC located?
Pathoseq Bio, LLC's physical address in SAM.gov is 4982 S 177th Cir, Omaha, NE 68135, USA.
Is Pathoseq Bio, LLC registered in SAM.gov?
Yes. Pathoseq Bio, LLC's SAM.gov registration is active through May 26, 2027.
What is Pathoseq Bio, LLC's most recent federal award?
Pathoseq Bio, LLC's most recent federal contract award is FFP labor (N0018925PZ542), from Naval Supply Systems Command, on September 23, 2025.
On GovTribe
See Pathoseq Bio, LLC's full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors